Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Ashesh Kumar

CEO & Director: Biologics & Licensing

Paras Biopharmaceuticals Finland Oy

Oulu, Finland

3 profile visits

Paras Biopharma is Finland based Biopharma company advancing with European Medicine Agency with Blood Disorder ITP product, Romiplostim. Paras Biopharma also brings other high value Biologics pipeline and CDMO work,

My organisation

About Paras Biopharmaceuticals Finland Oy: Paras Biopharmaceuticals Finland Oy is a Finnish biopharmaceuticals company having niche expertise in producing microbial-based biopharmaceutical products. After its inception in 2012, the company heavily focused on investing in developing microbial technologies for efficient production of microbial biologics. As a result of sustained efforts from the team comprising of protein scientists, bioprocess engineers and technologists and a strong experience in developing biologics in a most efficient manner, Paras Biopharma successfully developed these unique technologies having role in enabling and enhancing the production of intricate recombinant proteins. Paras Biopharma technologies have been successfully used for production of difficult-to-express proteins such as nanobodies, peptibodies, antibody fragments, long peptides, fusion proteins etc. Company activities & offerings are categorized in 3 major areas: End-to-end services for Contract Development & Microbial Biologics Manufacturing (CDMO). Development of Recombinant expression systems and process technologies for biologics and biosimilars. Development and offering of Recombinant Bioprocess Enzymes.
Read more